{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:57:40Z","timestamp":1789232260507,"version":"build-2803163510"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157437","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T14:56:52Z","timestamp":1466089012000},"page":"e0157437","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2)"],"prefix":"10.1371","volume":"11","author":[{"given":"Elad","family":"Asher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsalan","family":"Abu-Much","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Sabbag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Mazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meital","family":"Shlezinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaul","family":"Atar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Zahger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Beigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Matetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Platelets and Thrombosis in Sheba-PLATIS Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"L Mauri","year":"2007","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1097-0304(199711)42:3<243::AID-CCD1>3.0.CO;2-C","article-title":"Early versus late coronary stenting following acute myocardial infarction: results of the STENTIMI Study (French Registry of Stenting in Acute Myocardial Infarction)","volume":"42","author":"JP Monassier","year":"1997","journal-title":"Cathet Cardiovasc Diagn"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.amjcard.2006.02.039","article-title":"Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long term follow-up","volume":"98","author":"DW Park","year":"2006","journal-title":"Am J Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"I Iakovou","year":"2005","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.108.804203","article-title":"Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents. (The Acute Catheterization and Urgent Intervention Triage Strategy Trial)","volume":"119","author":"J Aoki","year":"2009","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ahj.2009.09.020","article-title":"The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome","volume":"159","author":"R Beinart","year":"2010","journal-title":"Am Heart J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.113.002589","article-title":"Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO Trial","volume":"128","author":"PG Steg","year":"2013","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.01.003","article-title":"Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) Trial","volume":"157","author":"S James","year":"2009","journal-title":"Am Heart J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"SD Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0003319712467530","article-title":"Pharmacotherapeutic considerations for the use of prasugrel and ticagrelor to reduce stent thrombosis in patients with acute coronary syndrome","volume":"65","author":"R Piccolo","year":"2014","journal-title":"Angiology"},{"issue":"11_S","key":"ref11","article-title":"The increased risk of stent thrombosis in acute coronary syndromes is confined to the first 30 days after PCI. Results from the Multicenter ADAPT-DES Study","volume":"64","author":"AJ Kirtane","year":"2014","journal-title":"Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"ATLANTIC Investigators. Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"G Montalescot","year":"2014","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"Intracoronary stenting and antithrombotic regimen: Safety and efficacy of 6 months dual antiplatelet therapy after drug-eluting stenting: (ISAR-SAFE) Trial Investigators. (A randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting)","volume":"36","author":"S Schulz-Sch\u00fcpke","year":"2015","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"SJ Park","year":"2010","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin. ITALIC, a randomized multicenter trial","volume":"65","author":"M Gilard","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/eurheartj\/ehv038","article-title":"Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY\u2014Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia trial","volume":"36","author":"F Costa","year":"2015","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus versus Cypher to Reduce Late Loss after Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"HC Gwon","year":"2012","journal-title":"Circulation"},{"key":"ref18","first-page":"1340","article-title":"RESET Investigators. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"BK Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ahj.2012.09.009","article-title":"Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter study","volume":"164","author":"F Feres","year":"2012","journal-title":"Am Heart J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy. (The SECURITY randomized clinical trial)","volume":"64","author":"A Colombo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"L Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"ref22","unstructured":"Prometheous trial\u2014Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions, San Diego 2015."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"D Sibbing","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2007.01.094","article-title":"Impact of platelet reactivity after clopidogrel administration on drug eluting stent thrombosis","volume":"49","author":"P Bounamici","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Investigators of the GRAVITAS randomized trial. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention","volume":"305","author":"MJ Price","year":"2011","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"ARCTIC Investigators. Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"JP Collet","year":"2013","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","article-title":"A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents. Results of the TRIGGER-PCI (Testing Platelet Reactivity in Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy with Prasugrel) study","volume":"59","author":"D Trenk","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis. The Dutch Stent Thrombosis Registry.","volume":"53","author":"JW van Werkum","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/CIRCULATIONAHA.110.981688","article-title":"Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Investigators. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction","volume":"123","author":"GD Dangas","year":"2011","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1161\/CIRCULATIONAHA.104.532242","article-title":"Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry","volume":"113","author":"P Urban","year":"2006","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Results from the PREMIER Registry","volume":"113","author":"JA Spertus","year":"2006","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"AV Finn","year":"2007","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/01.CIR.89.5.2026","article-title":"Intracoronary ultrasound observations during stent implantation","volume":"89","author":"S Nakamura","year":"1994","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/0735-1097(94)90861-3","article-title":"Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents","volume":"24","author":"SL Goldberg","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1161\/01.CIR.91.6.1676","article-title":"Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance","volume":"91","author":"A Colombo","year":"1995","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","article-title":"Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a Science Advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians","volume":"115","author":"CL Grines","year":"2007","journal-title":"Circulation"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"PW Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.jacc.2014.02.607","article-title":"Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study","volume":"63","author":"M Nakano","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1160\/TH15-05-0384","article-title":"Prior chronic clopidogrel therapy is associated with increased adverse events and early stent thrombosis","volume":"115","author":"E Asher","year":"2016","journal-title":"Thromb Haemost"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:51:23Z","timestamp":1540201883000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157437"}},"subtitle":[],"editor":[{"given":"Michael J","family":"Lipinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157437","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]}}}